According to a new report from Intel Market Research, the global Methyl 4-aminobenzoate market was valued at USD 12.6 million in 2024 and is projected to reach USD 17.1 million by 2031, growing at a steady CAGR of 3.8% during the forecast period (2025-2031). This growth is propelled by increasing pharmaceutical applications and expanding use in sunscreen formulations, alongside emerging opportunities in advanced material sciences.
Read MoreAccording to new market research from Intel Market Research, the global Embryo Selection Tool market was valued at USD 33.6 million in 2024 and is projected to reach USD 46.5 million by 2031, growing at a steady CAGR of 4.9% during the forecast period (2025-2031). This growth is fueled by widespread adoption of AI-driven fertility solutions, increasing global IVF procedures, and technological advancements in reproductive medicine.
Read MoreAccording to a new report from Intel Market Research, the global Bupropion Hydrochloride Extended-Release Tablets market was valued at USD 4,174 million in 2024 and is projected to reach USD 5,720 million by 2031, growing at a steady CAGR of 4.7% during the forecast period (2025-2031). This growth reflects the expanding use of bupropion in treating major depressive disorders and smoking cessation, coupled with increasing mental health awareness worldwide.
Read MoreAccording to new market research from Intel Market Research, the global Embryo Selection Tool market was valued at USD 33.6 million in 2024 and is projected to reach USD 46.5 million by 2031, growing at a steady CAGR of 4.9% during the forecast period (2025-2031). This growth is fueled by widespread adoption of AI-driven fertility solutions, increasing global IVF procedures, and technological advancements in reproductive medicine.
Read MoreAccording to a new report from Intel Market Research, the global Etonogestrel market was valued at USD 852 million in 2024 and is projected to reach USD 1,128 million by 2031, growing at a CAGR of 4.2% during the forecast period (2025-2031). This steady growth is driven by rising demand for hormonal contraceptives, increasing awareness about family planning, and expanding applications in gynecological treatments.
Read More